Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PERRIGO R AND D

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 40
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 42
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 44
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

SANDOZ

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 50
  • 0 comments

FDA approve TREPROSTINIL

Comment Full text

HAINAN POLY

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 42
  • 0 comments

FDA approve PHENYLEPHRINE HYDROCHLORIDE

Comment Full text

NORWICH PHARMACEUTICALS INC

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 36
  • 0 comments

FDA approve RIFAXIMIN

Comment Full text

LUPIN LTD

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 40
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

TARO

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 41
  • 0 comments

FDA approve CLOBETASOL PROPIONATE

Comment Full text

GRAVITI PHARMS

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 37
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text

ZYDUS

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 42
  • 0 comments

FDA approve CHLORPROMAZINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 527
  • 528
  • 529
  • 530
  • 531
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239534)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin